Similar articles

• Nomifensine in hyperprolactinemic states.

  Müller EE, Camanni F, Genazzani AR. Müller EE, et al. J Endocrinol Invest. 1984 Aug;7(4):421. doi: 10.1007/BF03351028. J Endocrinol Invest. 1984. PMID: 6438225 No abstract available.
• Nomifensine test for investigation of hyperprolactinaemia.

  Dunne MJ, Walker J, Cowden EA, Ratcliffe JG. Dunne MJ, et al. Lancet. 1979 Dec 8;2(8154):1243. doi: 10.1016/s0140-6736(79)92360-2. Lancet. 1979. PMID: 92650 Clinical Trial. No abstract available.
• Prolactin responsiveness to nomifensine in patients with hyperprolactinemia of tumorous or uncertain etiology.

  Camanni F, Genazzani AR, Massara F, de Leo V, Molinatti GM, Müller EE. Camanni F, et al. J Clin Endocrinol Metab. 1980 Sep;51(3):650-3. doi: 10.1210/jcem-51-3-650. J Clin Endocrinol Metab. 1980. PMID: 7410539 No abstract available.
• Pharmacodynamics of nomifensine: a review of studies in healthy subjects.

  Siegfried K, Taeuber K. Siegfried K, et al. J Clin Psychiatry. 1984 Apr;45(4 Pt 2):33-8. J Clin Psychiatry. 1984. PMID: 6370972 Review.
• [Nomifensine: clinical data (author's transl)].

  Clerc G, Cayreyre M. Clerc G, et al. Nouv Presse Med. 1978 Jun 28;7(26):2295-304. Nouv Presse Med. 1978. PMID: 353720 Review. French.